Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ALTANDRANO, RODRIGO |
| Género | Hombre |
| Área Principal WOS | Cardiac & Cardiovascular Systems; |
| Afiliación Principal | Universidad De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| Autor | Género | # Pub |
|---|---|---|
| GARCIA-NANNIG, LORENA DEL PILAR | Mujer | 1 |
| VERDEJO, HUGO E. | Hombre | 1 |
| ENRIQUEZ, ANDRES | Hombre | 1 |
| MELLADO-SUAZO, ROSEMARIE | Mujer | 1 |
| CONCEPCION-CHACON, ROBERTO | Hombre | 1 |
| SEPULVEDA-VARELA, PABLO | Hombre | 1 |
| ROSSEL, VALERIA | Mujer | 1 |
| QUINTANA-FRESNO, JUAN CARLOS | Hombre | 1 |
| SEPULVEDA, L. | Hombre | 1 |
| JALIL-MILAD, JORGE EMILIO | Hombre | 1 |
| CASTRO-GALVEZ, PABLO FEDERICO | Hombre | 1 |
| LUIS WINTER, JOSE | Hombre | 1 |
| ALTAMIRANO, RODRIGO | Hombre | 1 |
| CHIONG, MARIO | Hombre | 1 |
| LAVANDERO, SERGIO | Hombre | 1 |
| WINTER, JOSE LUIS | Hombre | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Altandrano, Rodrigo | Pontificia Universidad Catolica de Chile | 1.0 | 46.9 | 9.0 | 1.0 | 0.6 | 0.5 | 100.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 |
| 2019 | Altandrano, Rodrigo | Universidad de Chile | 1.0 | 46.9 | 9.0 | 1.0 | 0.6 | 0.5 | 100.0 | 0.0 | 0.0 | 0.0 | 100.0 | 0.0 | 0.0 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Effects Of Trimetazidine In Nonischemic Heart Failure: A Randomized Study | 2014 | 19 | artículo de investigación | Journal Of Cardiac Failure | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| artery | 1 |
| cardiac metabolism | 1 |
| coronary-artery-disease | 1 |
| disease | 1 |
| drug | 1 |
| dysfunction | 1 |
| energy-metabolism | 1 |
| failing heart | 1 |
| fatty-acid oxidation | 1 |
| heart failure | 1 |
| inhibition | 1 |
| ischemic cardiomyopathy | 1 |
| left-ventricular function | 1 |
| myocardial substrate metabolism | 1 |
| trimetazidine | 1 |